Your browser doesn't support javascript.
loading
Cerebrospinal Fluid Osteopontin and Inflammation-Associated Cytokines in Patients With Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Zou, Cong; Pei, Shanshan; Yan, Wei; Lu, Qingbo; Zhong, Xiaomei; Chen, Qiong; Pan, Suyue; Wang, Zhanhang; Wang, Honghao; Zheng, Dong.
Afiliação
  • Zou C; Department of Neurology, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.
  • Pei S; Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Yan W; Department of Neurology, The First People's Hospital of Kashgar Prefecture, Kashgar, China.
  • Lu Q; Department of Neurology, The First People's Hospital of Kashgar Prefecture, Kashgar, China.
  • Zhong X; Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Chen Q; Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Pan S; Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Wang Z; Department of Neurology, Guangdong 999 Brain Hospital, Guangzhou, China.
  • Wang H; Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Zheng D; Department of Neurology, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.
Front Neurol ; 11: 519692, 2020.
Article em En | MEDLINE | ID: mdl-33250837
ABSTRACT
Anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis is an autoimmune neurological disorder. Osteopontin (OPN) is a secreted multifunctional phosphorylated glycoprotein that regulates various autoimmune and inflammatory diseases, but its diagnostic and prognostic values in anti-NMDAR encephalitis patients remain elusive. This retrospective study aimed to determine the levels of OPN and related cytokines in cerebrospinal fluid (CSF) of anti-NMDAR encephalitis patients and to assess their influence on disease severity so as to evaluate their efficacy as biomarkers for diagnosis and prognosis. CSF samples from 33 anti-NMDAR encephalitis, 13 viral encephalitis, and 21 controls were collected. All CSF were tested for levels of OPN and inflammation-associated cytokines [interleukin (IL)-6, IL-10, and tumor necrosis factor (TNF)-α] via ELISA. In addition, 15 anti-NMDAR encephalitis patients without follow-up relapse were re-examined for these four parameters 3 months later. The clinical status was evaluated by modified Rankin Scale (mRS) scores. Results showed that the CSF levels of these cytokines were increased in anti-NMDAR encephalitis patients compared to controls but not viral encephalitis patients. Their levels were decreased in remission compared with that in acute stage. Moreover, CSF OPN positively correlated with IL-6, white blood cell (WBC) counts, and C-reactive protein (CRP) levels in anti-NMDAR encephalitis patients. However, no associations were found between OPN or related cytokines and mRS scores in acute stage in anti-NMDAR encephalitis patients. Overall, CSF OPN and related cytokines were increased when anti-NMDAR encephalitis patients are in acute stage and decreased in remission, suggesting the underlying neuro-inflammatory process in this disease. However, they are not qualified with diagnostic or prognostic value.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article